Cargando…

Mitochondrial Mechanisms in Diabetic Cardiomyopathy

Mitochondrial medicine is increasingly discussed as a promising therapeutic approach, given that mitochondrial defects are thought to contribute to many prevalent diseases and their complications. In individuals with diabetes mellitus (DM), defects in mitochondrial structure and function occur in ma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gollmer, Johannes, Zirlik, Andreas, Bugger, Heiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Diabetes Association 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7043970/ https://www.ncbi.nlm.nih.gov/pubmed/32097997 http://dx.doi.org/10.4093/dmj.2019.0185

Ejemplares similares

Established and Emerging Mechanisms of Diabetic Cardiomyopathy
por: Gollmer, Johannes, et al.
Publicado: (2019)

Mitochondrial Mechanisms in Septic Cardiomyopathy
por: Cimolai, María Cecilia, et al.
Publicado: (2015)

Complications and mortality of cardiovascular emergency admissions during COVID-19 associated restrictive measures
por: Bugger, Heiko, et al.
Publicado: (2020)

Impact of COVID-19 on Cardiovascular Disease
por: Vosko, Ivan, et al.
Publicado: (2023)

Diabetic Cardiomyopathy: Does the Type of Diabetes Matter?
por: Hölscher, Maximilian E., et al.
Publicado: (2016)

Dysregulation of the Mitochondrial Proteome Occurs in Mice Lacking Adiponectin Receptor 1
por: Pepin, Mark E., et al.
Publicado: (2019)

Myocardial Deformation Analysis in MYBPC3 and MYH7 Related Sarcomeric Hypertrophic Cardiomyopathy—The Graz Hypertrophic Cardiomyopathy Registry
por: Höller, Viktoria, et al.
Publicado: (2021)

Cellular Heterogeneity of the Heart
por: Anto Michel, Nathaly, et al.
Publicado: (2022)

Mitochondrial Quality Control Mechanisms during Diabetic Cardiomyopathy
por: Ketenci, Melis, et al.
Publicado: (2022)

Mass Spectrometry-Based Redox and Protein Profiling of Failing Human Hearts
por: Tomin, Tamara, et al.
Publicado: (2021)

NAD(+) and Vascular Dysfunction: From Mechanisms to Therapeutic Opportunities
por: Abdellatif, Mahmoud, et al.
Publicado: (2022)

The Role of Mitochondrial Abnormalities in Diabetic Cardiomyopathy
por: Dabravolski, Siarhei A., et al.
Publicado: (2022)

Mitochondrial quality control in diabetic cardiomyopathy: from molecular mechanisms to therapeutic strategies
por: Cai, Chen, et al.
Publicado: (2022)

Outcomes of ECLS-SHOCK Eligibility Criteria Applied to a Real-World Cohort
por: von Lewinski, Dirk, et al.
Publicado: (2023)

The potential mechanism of mitochondrial dysfunction in septic cardiomyopathy
por: Pan, Pan, et al.
Publicado: (2018)

The Role of Mitochondrial Biogenesis Dysfunction in Diabetic Cardiomyopathy
por: Tao, Li-Chan, et al.
Publicado: (2022)

Molecular Mechanisms of Mitochondrial Quality Control in Ischemic Cardiomyopathy
por: Chang, Xing, et al.
Publicado: (2023)

Effects of Short Term Adiponectin Receptor Agonism on Cardiac Function and Energetics in Diabetic db/db Mice
por: Tarkhnishvili, Aleksandre, et al.
Publicado: (2022)

Tissue-Specific Remodeling of the Mitochondrial Proteome in Type 1 Diabetic Akita Mice
por: Bugger, Heiko, et al.
Publicado: (2009)

Mitochondrial NAD(+)/NADH Redox State and Diabetic Cardiomyopathy
por: Berthiaume, Jessica M., et al.
Publicado: (2019)

Highlight: Mitochondrial Mechanisms in Septic Cardiomyopathy
Publicado: (2015)

Of mice and men: models and mechanisms of diabetic cardiomyopathy
por: Riehle, Christian, et al.
Publicado: (2018)

Mitochondrial Dysfunction in Diabetic Cardiomyopathy: The Possible Therapeutic Roles of Phenolic Acids
por: Jubaidi, Fatin Farhana, et al.
Publicado: (2020)

Mitochondrial Protein Homeostasis and Cardiomyopathy
por: Wachoski-Dark, Emily, et al.
Publicado: (2022)

Editorial of Special Issue “Sirtuins in Health and Disease”
por: Sedej, Simon, et al.
Publicado: (2021)

Mitochondrial Genome Variants as a Cause of Mitochondrial Cardiomyopathy
por: Campbell, Teresa, et al.
Publicado: (2022)

Effects of Bergamot Polyphenols on Mitochondrial Dysfunction and Sarcoplasmic Reticulum Stress in Diabetic Cardiomyopathy
por: Maiuolo, Jessica, et al.
Publicado: (2021)

Mitochondrial ROS Formation in the Pathogenesis of Diabetic Cardiomyopathy
por: Kaludercic, Nina, et al.
Publicado: (2020)

Therapeutic Approach of Flavonoid in Ameliorating Diabetic Cardiomyopathy by Targeting Mitochondrial-Induced Oxidative Stress
por: Sapian, Syaifuzah, et al.
Publicado: (2021)

Resveratrol and Diabetic Cardiomyopathy: Focusing on the Protective Signaling Mechanisms
por: Song, Yan-Jun, et al.
Publicado: (2020)

The Molecular Mechanisms of Defective Copper Metabolism in Diabetic Cardiomyopathy
por: Cui, Xiangning, et al.
Publicado: (2022)

Role of Echocardiography in Diabetic Cardiomyopathy: From Mechanisms to Clinical Practice
por: Urlic, Hrvoje, et al.
Publicado: (2023)

Mitochondrial Cardiomyopathies
por: El-Hattab, Ayman W., et al.
Publicado: (2016)

Can We Prevent Mitochondrial Dysfunction and Diabetic Cardiomyopathy in Type 1 Diabetes Mellitus? Pathophysiology and Treatment Options
por: Cieluch, Aleksandra, et al.
Publicado: (2020)

Involvement of Mitochondrial Disorders in Septic Cardiomyopathy
por: Durand, Arthur, et al.
Publicado: (2017)

SIRT3 in Cardiac Physiology and Disease
por: Koentges, Christoph, et al.
Publicado: (2016)

Diabetic cardiomyopathy
por: Asghar, Omar, et al.
Publicado: (2009)

Ca(2+) mishandling and mitochondrial dysfunction: a converging road to prediabetic and diabetic cardiomyopathy
por: Jaquenod De Giusti, Carolina, et al.
Publicado: (2022)

Insulin Signaling Regulates Mitochondrial Function in Pancreatic β-Cells
por: Liu, Siming, et al.
Publicado: (2009)

Cellular mechanisms of cardiomyopathy
por: Harvey, Pamela A., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_inon3bgodp69er137889nhdicu